Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · Real-Time Price · USD
14.34
+0.01 (0.03%)
Mar 5, 2026, 2:30 PM EST - Market open
Amicus Therapeutics Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
$27.25
Upside
+90.09%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $16 → $15 | Strong Buy → Hold | Downgrades | $16 → $15 | +1.15% | Jan 22, 2026 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $17 → $15 | Buy → Hold | Downgrades | $17 → $15 | +1.15% | Dec 29, 2025 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $17 → $15 | Strong Buy → Hold | Downgrades | $17 → $15 | +1.15% | Dec 22, 2025 |
| Needham | Needham | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 19, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades $21 → $15 | Buy → Hold | Downgrades | $21 → $15 | +1.15% | Dec 19, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $17 | Strong Buy | Initiates | $17 | +18.59% | Dec 17, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $18 → $19 | Buy | Maintains | $18 → $19 | +32.54% | Nov 6, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $9 → $11 | Hold | Maintains | $9 → $11 | -23.26% | Nov 5, 2025 |
| Needham | Needham | Hold → Strong Buy Upgrades $14 | Hold → Strong Buy | Upgrades | $14 | -2.34% | Sep 18, 2025 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $102 → $108 | Hold → Buy | Upgrades | $102 → $108 | +653.40% | Jul 17, 2025 |
| UBS | UBS | Strong Buy Maintains $21 → $22 | Strong Buy | Maintains | $21 → $22 | +53.47% | May 2, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $12 → $9 | Hold | Maintains | $12 → $9 | -37.22% | May 2, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $18 → $17 | Buy | Maintains | $18 → $17 | +18.59% | Feb 20, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 20, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $21 | Buy | Reiterates | $21 | +46.49% | Jan 15, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 13, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.